Opioid peptides are not recycled like monoamine neurotransmitters. They are cleaved from propeptides that contain multiple other peptides. Monoamines are reuptaken for recycling purposes, they are packed into vesicles and re-released after uptake. It doesn't make sense for peptides to share such a mechanism.
That being said, I believe that there may be a transporter for endorphins and other peptides, but no data has shown if those are its main traffic, or simply passengers due to similarities to other peptides. Finally there is no data whatsoever on the fate of these peptides once inside the cell. They could be contributing to intracellular signalling or even being catabolized for their constituents.
If this re-uptake mechanism was valid, there would be a lot more research corroborating it, because its hella interesting and an extremely enticing drug target. The lack of people taking it further could be due to lack of techniques to study it, but it could also be because it is not a significant player in peptide signaling.
I think a lot of the compounds mentioned such as nicotine function by increasing the release of mu active peptides, not by inhibiting their reuptake.
I find it hard to believe that reuptake is a larger mechanism of terminating signalling than action of peptidases which are much more ubiquitous.